Brian Austad - Tewksbury MA, US Mark L. Behnke - Somerville MA, US Alfredo C. Castro - Winchester MA, US Michael J. Grogan - Winchester MA, US Andre Lescarbeau - Somerville MA, US Stephane Peluso - Somerville MA, US Martin Tremblay - Melrose MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 401/00 C07D 515/02
US Classification:
546 17, 546115, 549331, 549345
Abstract:
The invention provides novel derivatives of cyclopamine having the following formula:.
Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners
Alfredo C. Castro - Winchester MA, US Kristopher M. Depew - Acton MA, US Michael J. Grogan - Winchester MA, US Charles W. Johannes - Newbury MA, US Edward B. Holson - Newton Highlands MA, US Brian T. Hopkins - Newton MA, US Gregg F. Keaney - Belmont MA, US Nii O. Koney - Brighton MA, US Tao Liu - Ashland MA, US David A. Mann - Swampscott MA, US Marta Nevalainen - Quincy MA, US Stephane Peluso - Somerville MA, US Lawrence B. Perez - Hopkinton MA, US Daniel A. Snyder - Somerville MA, US Thomas T. Tibbitts - Westford MA, US
Assignee:
Infinity Discovery, Inc. - Cambridge MA
International Classification:
C07D 261/02 A61K 31/42
US Classification:
548240, 514378
Abstract:
The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
Substituted Pyrrolo[2,3-D]Pyrimidines As Inhibitors Of E1 Activating Enzymes
Stephen Critchley - Braintree MA, US Thomas G. Gant - Carlsbad CA, US Steven P. Langston - North Andover MA, US Edward J. Olhava - Brookline MA, US Stephane Peluso - Somerville MA, US
Christopher F. Claiborne - Cambridge MA, US Stephen Critchley - Braintree MA, US Courtney Cullis - Bedford MA, US Steven P. Langston - North Andover MA, US Hirotake Mizutani - Cambridge MA, US Edward J. Olhava - Cambridge MA, US Stephane Peluso - Somerville MA, US Irache Visiers - Arlington MA, US Stepan Vyskocil - Watertown MA, US Gabriel S. Weatherhead - Salem MA, US
This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners
Alfredo C. Castro - Winchester MA, US Kristopher M. Depew - Acton MA, US Michael J. Grogan - Winchester MA, US Charles W. Johannes - Newbury MA, US Edward B. Holson - Newton Highlands MA, US Brian T. Hopkins - Newton MA, US Gregg F. Keaney - Belmont MA, US Nii O. Koney - New York NY, US Tao Liu - Ashland MA, US David A. Mann - Madison WI, US Marta Nevalainen - Quincy MA, US Stephane Peluso - Somerville MA, US Lawrence Blas Perez - Hopkinton MA, US Daniel A. Snyder - Somerville MA, US Thomas T. Tibbitts - Westford MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
C07D 261/02 A61K 31/42
US Classification:
548240, 514378
Abstract:
The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.
Compounds And Methods For Inhibiting The Interaction Of Bcl Proteins With Binding Partners
Alfredo C. Castro - Winchester MA, US Michael J. Grogan - Winchester MA, US Edward B. Holson - Newton Highlands MA, US Brian T. Hopkins - Newton MA, US Nii O. Koney - New York NY, US Stephane Peluso - Somerville MA, US Daniel A. Snyder - Somerville MA, US
Assignee:
Infinity Discovery, Inc. - Cambridge MA
International Classification:
A61K 31/445
US Classification:
514315, 514365, 514423
Abstract:
The present invention relates to heterocyclic compounds that bind to Bcl proteins and inhibit Bcl function, compositions comprising such compounds, and methods for treating and modulating disorders associated with hyperproliferation, such as cancer.
Adilah Bahadoor - Cambridge MA, US Alfredo C. Castro - Winchester MA, US Lawrence K. Chan - Brookline MA, US Gregg F. Keaney - Lexington MA, US Marta Nevalainen - Weymouth MA, US Vesa Nevalainen - Weymouth MA, US Stephane Peluso - Brookline MA, US Thomas T. Tibbitts - Westford MA, US
Assignee:
Infinity Pharmaceuticals, Inc. - Cambridge MA
International Classification:
A61K 31/41 A61K 31/4192 C07D 249/00 C07D 249/06
US Classification:
514359, 548255
Abstract:
Provided herein are triazole FASN inhibitors of the formula (I):Also provided herein are pharmaceutical compositions of the compounds provided herein as well as methods of their use for the treatment of various disorders such as hyperproliferative disorders, inflammatory disorders, obesity-related disorders and microbial infections.
Heteroaryl Compounds Useful As Inhibitors Of E1 Activating Enzymes
Christopher F. Claiborne - Cambridge MA, US Stephen Critchley - Braintree MA, US Courtney A. Cullis - Bedford MA, US Steven P. Langston - North Andover MA, US Hirotake Mizutani - Cambridge MA, US Edward J. Olhava - Newton MA, US Stephane Peluso - Somerville MA, US Irache Visiers - Arlington MA, US Stepan Vyskocil - Arlington MA, US Gabriel S. Weatherhead - Tewksbury MA, US
This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
Youtube
Dana cover-Rockstar Rebeldes
Ficou lindoo.
Category:
People & Blogs
Uploaded:
28 Aug, 2012
Duration:
3m 54s
Stephane Peluso YouTube
Stephane Peluso uploaded and added to Favorites 42 minutes ago. Thumbn...